Skip to content

Opening book details…

About this Medicine article

Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies by Howard, Campbell; Noe, Adele; Skerjanec, Andrej; Holzhauer, Björn; Wernsing, Margaret; Ligueros-Saylan, Monica; Thuren, Tom is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Howard, Campbell; Noe, Adele; Skerjanec, Andrej; Holzhauer, Björn; Wernsing, Margaret; Ligueros-Saylan, Monica; Thuren, Tom
Publisher
BioMed Central; Springer (Biomed Central Ltd.); London: BioMed Central, 2002-; Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 1475-2840)
Published
2014
Language
EN
Field
Medicine (Health Sciences)

More by Howard, Campbell; Noe, Adele; Skerjanec, Andrej; Holzhauer, Björn; Wernsing, Margaret; Ligueros-Saylan, Monica; Thuren, Tom

Browse all works by Howard, Campbell; Noe, Adele; Skerjanec, Andrej; Holzhauer, Björn; Wernsing, Margaret; Ligueros-Saylan, Monica; Thuren, Tom